Prescription Weight Loss Medications and Nutritional Risks

from TheBrief.Health · host TheBrief.Health

Study warns users of GLP-1 weight loss drugs may lack nutritional guidance, risking deficiencies and muscle loss, urging structured dietary support alongside semaglutide and tirzepatide therapy.

Episode metadata supplied by the publisher feed · Published Jan 8, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Prescription Weight Loss Medications and Nutritional Risks

0:00 1:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on January 8, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!